Recovered COVID-19 Patients Needed to Give Blood for Critical Research

Medical scientists need patient plasma & immune cells for COVID-19 treatment development & potential vaccine discovery. Recovered patients’ white blood cells can help researchers understand the body’s immune response to the virus to learn how to protect others & help control the spread of the disease.

Recovered patients’ blood also may be used to create therapeutic agents for use in clinical trials that would involve actively ill patients and healthy volunteers. No potential treatment or experimental vaccine will be administered to recovered patient blood donors.

Recovered patient blood donors will be compensated up to $700 for their time & effort: telephone or video calls and 2-3 appointments, including a blood collection appointment that may last 5 hours.

All in-person activities include CDC recommended screening & social distancing measures for donor protection.